Abstract: A system for treating a linear wound on a patient has a closing dressing bolster for placing on the patient's epidermis over the linear wound, a sealing subsystem for providing a seal over the closing dressing bolster and the patient, and a reduced-pressure subsystem for delivering reduced pressure to the sealing subsystem. The sealing subsystem and reduced pressure subsystem are operable to deliver reduced pressure to the closing dressing bolster. The closing dressing bolster is operable under reduced pressure to develop a inward closing. The closing dressing bolster may include one or more closing members on each side of a center wound area to create the inward closing when under reduced pressure. A compressive force may also be developed. Other systems and methods are presented.

Abstract: A medical canister connector is presented for connecting to a medical canister, which has a patient port and a reduced-pressure port. The medical canister connector includes a first connection member that is coupled to a patient-port-attachment member, which is for coupling to a patient port on a medical canister and has a patient-port opening with a first longitudinal axis. The medical canister connector also includes a second connection member coupled to a reduced-pressure -port-attachment member, which is for coupling to a reduced-pressure port on the medical canister and has a reduced-pressure-port opening with a second longitudinal axis. A spacing member or pressure transport member may be used to couple the first connection member to the second connection member. The spacing member or transport member flexes and twists during connection. The medical canister connector may also help organize one or more pressure-sensing conduits. Methods are also presented.

Abstract: Fluid supply systems and methods for therapeutic fluid delivery systems, including those used for negative pressure wound therapy (NPWT) systems and methods.

Abstract: A method and device for transferring fluids from a non-sterile field to a sterile field within a surgical environment includes utilizing a device that includes a main body having a first inlet port that is in communication with a first outlet port. Fluid is taken from the patient, typically with a sterile syringe and transferred to the non-sterile field where the fluid is processed. The processed fluid is then drawn into another syringe in the non-sterile field and a distal end of the first syringe is place within the inlet port of the sterile main body. A distal end of a second sterile syringe is inserted into the outlet port, where the distal ends of the sterile syringe and the non-sterile syringe do not make contact. As a plunger is forced into a chamber of the first non-sterile syringe to force the fluid out of the first syringe, the plunger of the second sterile syringe is retracted such that a chamber in the second syringe has a sufficient volume to store the processed liquid.

Abstract: Fluid supply systems and methods for therapeutic fluid delivery systems, including those used for negative pressure wound therapy (NPWT) systems and methods.

Abstract: A canister for use in administering reduced pressure to a tissue site includes a center body, a first end cap, and a second end cap. The center body includes a first end, second end, and a number of fluidly separate body conduits. The first end cap is connected to the first end of the center body and includes a number of return conduits fluidly connecting one body conduit to another. The first end has a port for receiving a conduit in fluid communication with the tissue site. The second end cap is connected to the second end of the center body and includes a number of return conduits fluidly connecting one body conduit to another. The second end cap has a port for receiving a conduit in fluid communication with a reduced pressure source. The fluid connection between the body conduits and the return conduits creates a continuous, tortuous pathway.

Abstract: A closing dressing bolster and assembly for use with a system for treating a linear wound on a patient includes a bolster body formed from a flexible closing bolster material having closing members that are operable to develop an inward closing force when the closing dressing bolster is placed under reduced pressure. In one aspect, when the closing dressing bolster is under reduced pressure, the system, dressing, or assembly develops an inward force realized at the linear wound and a compression force. A wicking-material holder and wicking material may be used as well. The member components may all be see-through to allow visual inspection of the wound without requiring removal of the dressing.

Abstract: A textile structure is provided which comprises a backing of at least a first plurality of fibers and a second plurality of fibers, wherein the first plurality of fibers have a first fiber denier and the second plurality of fibers have a second fiber denier different than the first fiber denier. A method of providing a slip resistant covering to overlie a floor pan carpet of a motor vehicle is provided comprising overlying the carpet with an accessory mat having an underlying backing comprising at least a first plurality of fibers and a second plurality of fibers, wherein the first plurality of fibers have a first fiber denier and the second plurality of fibers have a second fiber denier different than the first fiber denier, and wherein the underlying backing of the accessory mat is configured to be in direct contact with the floor pan carpet.

Abstract: The teachings provided herein are generally directed to a method of converting lignin-derived compounds to valuable aromatic chemicals using an enzymatic, bioconversion process. The teachings provide a selection of (i) host cells that are tolerant to the toxic compounds present in lignin fractions; (ii) polypeptides that can be used as enzymes in the bioconversion of the lignin fractions to the aromatic chemical products; (iii) polynucleotides that can be used to transform the host cells to express the selection of polypeptides as enzymes in the bioconversion of the lignin fractions; and (iv) the transformants that express the enzymes.

Abstract: The teachings provided herein are generally directed to a method of converting lignin-derived compounds to valuable aromatic chemicals using an enzymatic, bioconversion process. The teachings provide a selection of (i) host cells that are tolerant to the toxic compounds present in lignin fractions; (ii) polypeptides that can be used as enzymes in the bioconversion of the lignin fractions to the aromatic chemical products; (iii) polynucleotides that can be used to transform the host cells to express the selection of polypeptides as enzymes in the bioconversion of the lignin fractions; and (iv) the transformants that express the enzymes.

Abstract: A see-through dressing assembly is presented for use with a reduced-pressure system for treating a wound on a patient using reduced pressure that allows visual observation of the wound during treatment. The dressing assembly includes a bolster for providing a directed force when under reduced pressure, a sealing member for covering the bolster and providing a seal over the bolster and a patient's epidermis, and wherein the bolster and sealing member are formed from see-through materials sufficient to allow perception of color from a point external to the system. Other systems, dressings, and methods are presented.

Abstract: The teachings provided herein are generally directed to a method of converting lignin-derived compounds to valuable aromatic chemicals using an enzymatic, bioconversion process. The teachings provide a selection of (i) host cells that are tolerant to the toxic compounds present in lignin fractions; (ii) polypeptides that can be used as enzymes in the bioconversion of the lignin fractions to the aromatic chemical products; (iii) polynucleotides that can be used to transform the host cells to express the selection of polypeptides as enzymes in the bioconversion of the lignin fractions; and (iv) the transformants that express the enzymes.

Abstract: The teachings provided herein are generally directed to a method of converting lignin-derived compounds to valuable aromatic chemicals using an enzymatic, bioconversion process. The teachings provide a selection of (i) host cells that are tolerant to the toxic compounds present in lignin fractions; (ii) polypeptides that can be used as enzymes in the bioconversion of the lignin fractions to the aromatic chemical products; (iii) polynucleotides that can be used to transform the host cells to express the selection of polypeptides as enzymes in the bioconversion of the lignin fractions; and (iv) the transformants that express the enzymes.

Abstract: A system for treating a linear wound on a patient has a closing dressing bolster for placing on the patient's epidermis over the linear wound, a sealing subsystem for providing a seal over the closing dressing bolster and the patient, and a reduced-pressure subsystem for delivering reduced pressure to the sealing subsystem. The sealing subsystem and reduced pressure subsystem are operable to deliver reduced pressure to the closing dressing bolster. The closing dressing bolster is operable under reduced pressure to develop a inward closing. The closing dressing bolster may include one or more closing members on each side of a center wound area to create the inward closing when under reduced pressure. A compressive force may also be developed. Other systems and methods are presented.

Abstract: A see-through dressing assembly is presented for use with a reduced-pressure system for treating a wound on a patient using reduced pressure that allows visual observation of the wound during treatment. The dressing assembly includes a bolster for providing a directed force when under reduced pressure, a sealing member for covering the bolster and providing a seal over the bolster and a patient's epidermis, and wherein the bolster and sealing member are formed from see-through materials sufficient to allow perception of color from a point external to the system. Other systems, dressings, and methods are presented.

Abstract: A system for treating a linear wound on a patient has a closing dressing bolster for placing on the patient's epidermis over the linear wound, a sealing subsystem for providing a seal over the closing dressing bolster and the patient, and a reduced-pressure subsystem for delivering reduced pressure to the sealing subsystem. The sealing subsystem and reduced pressure subsystem are operable to deliver reduced pressure to the closing dressing bolster. The closing dressing bolster is operable under reduced pressure to develop a inward closing. The closing dressing bolster may include one or more closing members on each side of a center wound area to create the inward closing when under reduced pressure. A compressive force may also be developed. Other systems and methods are presented.

Abstract: Surgical implants for neighboring bones are disclosed herein. Preferred implants are configured to be implanted into the scaphoid and lunate. Preferred implants include a first plate configured to be implanted into the scaphoid and a second plate configured to be implanted into the lunate wherein said first and second plates are couple together by a rotatable rod.

Abstract: Fluid supply systems and methods for therapeutic fluid delivery systems, including those used for negative pressure wound therapy (NPWT) systems and methods.

Abstract: Wound treatment systems and methods (e.g., having hydrophilic wound inserts), such as for negative-pressure and/or fluid-installation wound therapies. Some embodiments include a check-valve assembly between a wound dressing and a vacuum source.

Abstract: A method and device for transferring fluids from a non-sterile field to a sterile field within a surgical environment includes utilizing a device that includes a main body having a first inlet port that is in communication with a first outlet port. Fluid is taken from the patient, typically with a sterile syringe and transferred to the non-sterile field where the fluid is processed. The processed fluid is then drawn into another syringe in the non-sterile field and a distal end of the first syringe is place within the inlet port of the sterile main body. A distal end of a second sterile syringe is inserted into the outlet port, where the distal ends of the sterile syringe and the non-sterile syringe do not make contact. As a plunger is forced into a chamber of the first non-sterile syringe to force the fluid out of the first syringe, the plunger of the second sterile syringe is retracted such that a chamber in the second syringe has a sufficient volume to store the processed liquid.